4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-22-012474
Options or other derivatives
- Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| FRATES JAMES M Chief Financial Officer | 2022-02-11 | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X03/doc4.xml…